Reported about 23 hours ago
Despite a significant decline in shares since December 2022, Pfizer attracts investors with a 5.7% dividend yield. Recently, activist hedge fund Starboard Value, led by Jeffrey Smith, acquired a $1 billion stake aiming for better company performance. Pfizer has made extensive acquisitions, particularly in oncology, but faces challenges with product performance and expiring patents. Analysts suggest cautious optimism for future growth, particularly after the Seagen acquisition.
Source: YAHOO